

| Catalog No. | AB769518 |
|---|---|
| Description |
Anti-Ustekinumab Neutralizing Antibody ELISA kit (AB769518) — Quantitative sandwich ELISA for Anti-Ustekinumab Neutralizing Antibody. Sample: Plasma, Serum. Range: 15.625-1, 000 ng/ml.
Highlights
|
| Sample type | Serum, plasma, and other biological fluid samples |
| Sensitivity | 16.41 ng/mL |
| Range | 31.25 - 2,000 ng/mL |
| Species reactivity | Human |
| Target | IL12B/IL-12 p40 |
| Accession | P29460 |
| Applications | ELISA |
| Detection method | Colorimetric |
| Assay type | Competitive |
| Recovery | 80-120% |
| Shipping | 2-8 ℃ |
| Stability and Storage | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| Specifications | Ustekinumab |
| Alternate Names | CNTO 1275, TT-20, 815610-63-0 |
| Background | Ustekinumab with trade name Stelara, is an FDA-approved drug to Crohn's disease, Ulcerative Colitis, Plaque Psoriasis and Psoriatic Arthritis, targeting both interleukins (IL)-12 and IL-23. Ustekinumab is a fully human immunoglobulin G1 kappa mAb that binds to IL-12 and IL-23. Ustekinumab binds to the p40 subunit common to IL-12 and IL-23 and prevents their interaction with the IL-12 receptor β1 subunit of the IL-12 and IL-23 receptor complexes, thereby disrupting the proinflammatory pathway. Antibodysystem Anti-Ustekinumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Ustekinumab. |
| Note | For Research Use Only. |

Standard Curve of Anti-Ustekinumab Neutralizing Antibody ELISA kit




Contact us for custom quotes, bulk requests and any other issues.
Mail: [email protected]


Quick access
Contact Us
+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский